In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Professor Ulf Landmesser
Speaker
Professor Ulf Landmesser
Ulf Landmesser Ulf Landmesser

Charite University Hospital, Berlin (Germany)

Specialities : Interventional Cardiology , Coronary Artery Disease Chronic, Risk Factors and Prevention, e-Cardiology, Valvular Heart Disease

Professor Ulf Landmesser is Chairman of the Department of Cardiology of Charite University Medicine Berlin (CBF) and Professor of Cardiology at Berlin Institute of Health.

42 presentations from this speaker

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Commentary.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2021

  • Session : Let´s look at 2020´s most downloaded articles in the European Journal of Preventive Cardiology (EJPC)
  • Speaker : U Landmesser (Berlin,DE)

When statins are not enough: emerging pharmacological tools.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2021

  • Session : Dyslipidaemia and type 2 diabetes - the two ugly sisters
  • Speaker : U Landmesser (Berlin,DE)

Introduction.

Event : ESC Congress 2020

  • Session : Expanding focus for cardiologists: The diabetic patient and cardiovascular outcomes
  • Speaker : U Landmesser (Berlin,DE)
  • Organised by PACE-CME, supported by Novo Nordisk A/S in the form of an educational grant

Management of dyslipidaemia - New 2019 guidelines.

Event : Webinar 2020

  • Session : ESC Webinars 2020
  • Speaker : C Baigent (Oxford,GB), U Landmesser (Berlin,DE), F Perone (Caserta,IT)

Patent foramen ovale and transient ischemic attack - Fix it.

Event : ESC Congress 2020

  • Session : Controversies in Patent Foramen Ovale Closure
  • Speaker : U Landmesser (Berlin,DE)

The residual risk challenge in CVD: How important are triglycerides?

Event : ESC Congress 2020

  • Session : Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides
  • Speaker : U Landmesser (Berlin,DE)
  • Organised by PACE-CME, supported by Amarin in the form of an educational grant

Discussion

Event : ESC Congress 2019

  • Session : Epigenetics: a new pathway to tackle residual risk?
  • Speaker : U Landmesser (Berlin,DE), KK Ray (London,GB)
  • Organised by PACE-CME, supported with an educational grant provided by Resverlogix

HDL-C, Triglycerides and Lp(a) - Role in the progression of coronary artery disease

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2019

  • Session : Management of dyslipidemia in the setting of cardiovascular prevention and rehabilitation
  • Speaker : U Landmesser (Berlin,DE)
  • Joint Session with Saudi Group for Cardiovascular Prevention and Rehabilitation (SGCVPR) at Saudi Heart Association

Introduction

Event : ESC Congress 2019

  • Session : Epigenetics: a new pathway to tackle residual risk?
  • Speaker : U Landmesser (Berlin,DE)
  • Organised by PACE-CME, supported with an educational grant provided by Resverlogix

Introduction.

Event : ESC Congress 2019

  • Session : Novel ESC Guidelines 2019 – Clinical cases put into practice
  • Speaker : U Landmesser (Berlin,DE)

LAA occlusion: current indications and results.

Event : ESC Congress 2019

  • Session : Stroke prevention - Cardiologists have a central role!
  • Speaker : U Landmesser (Berlin,DE)

Putting the updated ESC/EAS guidelines in to practice - Expert panel discussion

Event : ESC Congress 2019

  • Session : A deep dive in to guidelines - Combination therapy, a cornerstone in CV risk reduction
  • Speaker : A Catapano (Milan,IT), Z Reiner (Zagreb,HR), U Landmesser (Berlin,DE), R Santos (Sao Paulo,BR), M Farnier (Fixin,FR)
  • Sponsored by Sanofi-Aventis Groupe

Summary and audience questions and answers

Event : ESC Congress 2019

  • Session : A deep dive in to guidelines - Combination therapy, a cornerstone in CV risk reduction
  • Speaker : A Catapano (Milan,IT), Z Reiner (Zagreb,HR), U Landmesser (Berlin,DE), R Santos (Sao Paulo,BR), M Farnier (Fixin,FR)
  • Sponsored by Sanofi-Aventis Groupe

The role of the gut microbiome and its impact on CVD disease

Event : ESC Congress 2019

  • Session : Diet and risk reduction of cardiovascular disease - Evidence, controversies, and consensus
  • Speaker : U Landmesser (Berlin,DE)
  • Sponsored by Cleveland Clinic

What’s new in the guidelines

Event : ESC Congress 2019

  • Session : A deep dive in to guidelines - Combination therapy, a cornerstone in CV risk reduction
  • Speaker : U Landmesser (Berlin,DE)
  • Sponsored by Sanofi-Aventis Groupe

Advancing standard of care in post-myocardial infarction (MI) patients with elevated high sensitivity C-reactive protein (hsCRP).

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : Inflammation in atherosclerosis: translating science into practicable solutions.
  • Speaker : U Landmesser (Berlin,DE), P Libby (Boston,US), W Koenig (Munich,DE)
  • Sponsored by Novartis Pharma AG

Biomarkers and cardiovascular risk prediction.

Event : Frontiers in CardioVascular Biology 2018

  • Session : Hot topic - Biomarkers and cardiovascular risk prediction
  • Speaker : U Landmesser (Berlin,DE)

Introduction - Treatment of ischemic heart disease patients in 2018

Event : ESC Congress 2018

  • Session : LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!
  • Speaker : U Landmesser (Berlin,DE)
  • Sponsored by Amgen Europe GmbH

Introduction.

Event : ESC Congress 2018

  • Session : Novel ESC Guidelines 2017/2018 – Clinical Cases put into perspective
  • Speaker : U Landmesser (Berlin,DE)
  • ESC Education committee

LAA occlusion is the upcoming standard treatment in atrial fibrillation with high stroke risk - PRO

Event : ESC Congress 2018

  • Session : LAA occlusion - The next big thing?
  • Speaker : U Landmesser (Berlin,DE)

LAA occlusion is the upcoming standard treatment in atrial fibrillation with high stroke risk - Rebuttal PRO

Event : ESC Congress 2018

  • Session : LAA occlusion - The next big thing?
  • Speaker : U Landmesser (Berlin,DE)

LAA occlusion: Indications, results and complications

Event : ESC Congress 2018

  • Session : An update on indications and results of left atrial interventions
  • Speaker : U Landmesser (Berlin,DE)

Panel discussion and wrap-up - LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!

Event : ESC Congress 2018

  • Session : LDL-cholesterol and secondary prevention of atherosclerotic disease - When less is definitely more!
  • Speaker : U Landmesser (Berlin,DE), C Ballantyne (Houston,US), KK Ray (London,GB)
  • Sponsored by Amgen Europe GmbH

Summary and closure - Inflammation in atherosclerosis: translating science into practicable solutions.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : Inflammation in atherosclerosis: translating science into practicable solutions.
  • Speaker : U Landmesser (Berlin,DE)
  • Sponsored by Novartis Pharma AG

Welcome and introduction - Inflammation in atherosclerosis: translating science into practicable solutions.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : Inflammation in atherosclerosis: translating science into practicable solutions.
  • Speaker : U Landmesser (Berlin,DE)
  • Sponsored by Novartis Pharma AG

A breakthrough in lipid therapy: from statins to PCSK9 inhibitors.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : The year in preventive cardiology
  • Speaker : U Landmesser (Berlin,DE)
  • Joint session with the European Heart Journal and the European Journal of Preventive Cardiology.

HDL/LDL and vascular remodelling.

Event : ESC Congress 2017

  • Session : Lipids in atherosclerosis - Evolving concepts
  • Speaker : U Landmesser (Berlin,DE)

Introduction: The ESC Journal Family on the move.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : The year in preventive cardiology
  • Speaker : U Landmesser (Berlin,DE)
  • Joint session with the European Heart Journal and the European Journal of Preventive Cardiology.

State of the Art: PCSK9 - Beyond lipid-lowering effects?

Event : ESC Congress 2017

  • Session : PCSK9: Beyond lipid - lowering effects?
  • Speaker : U Landmesser (Berlin,DE)

HDL a changing paradigm.

Event : ESC Congress 2016

  • Session : Is HDL atheroprotective? Current controversies
  • Speaker : U Landmesser (Berlin,DE)

Q&A and panel discussion - Cholesteryl ester transfer protein (CETP) inhibition: emerging science in LDL lowering.

Event : ESC Congress 2016

  • Session : Cholesteryl ester transfer protein (CETP) inhibition: emerging science in LDL lowering
  • Speaker : H Drexel (Feldkirch,AT), U Landmesser (Berlin,DE)
  • Sponsored by MSD

The clinical overview of inhibiting cholesteryl ester transfer protein (CETP).

Event : ESC Congress 2016

  • Session : Cholesteryl ester transfer protein (CETP) inhibition: emerging science in LDL lowering
  • Speaker : U Landmesser (Berlin,DE)
  • Sponsored by MSD

The future of LDL lowering Recent data from PCSK9 inhibitors and outlook for upcoming trials.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2016

  • Session : LDL-Cholesterol lowering at a turning point
  • Speaker : U Landmesser (Berlin,DE)

Welcome and introduction - Cholesteryl ester transfer protein (CETP) inhibition: emerging science in LDL lowering.

Event : ESC Congress 2016

  • Session : Cholesteryl ester transfer protein (CETP) inhibition: emerging science in LDL lowering
  • Speaker : H Drexel (Feldkirch,AT), U Landmesser (Berlin,DE)
  • Sponsored by MSD

Coronary artery disease and aortic stenosis: mechanisms of disease.

Event : ESC Congress 2015

  • Session : Coronary artery disease and aortic stenosis
  • Speaker : U Landmesser (Berlin,DE)

How to review a paper and how to get your papers published? Inside information from the European Journal of Preventive Cardiology and the European Heart Journal.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Session : Research after your PhD
  • Speaker : DE Grobbee (Utrecht,NL), U Landmesser (Berlin,DE)

Preventive cardiology.

Event : ESC Congress 2014

  • Session : Highlight session
  • Speaker : U Landmesser (Berlin,DE)

Effects of high-density lipoprotein on vascular function.

Event : ESC Congress 2013

  • Session : The high-density lipoprotein story: waiting for a happy ending
  • Speaker : U Landmesser (Berlin,DE)

HDL - still a therapeutic target?

Event : ESC Congress 2013

  • Session : The Best of the European Heart Journal. The year in coronary artery disease: from prevention to intervention
  • Speaker : U Landmesser (Berlin,DE)

How good is the peer review process?

Event : ESC Congress 2013

  • Session : Is the peer review process up for renewal?
  • Speaker : U Landmesser (Berlin,DE)

Preventive cardiology.

Event : ESC Congress 2013

  • Session : Highlight Session
  • Speaker : U Landmesser (Berlin,DE)

Stem cell therapy.

Event : ESC Congress 2013

  • Session : Novel adjunctive therapies in primary percutaneous coronary intervention
  • Speaker : U Landmesser (Berlin,DE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are